Last reviewed · How we verify
NCT04438330
The Immunological Profile of Nickel Dermatitis
NA trial testing Nickel sulfate hexahydrate in Nickel; Eczema in 26 participants. Completed in 1 June 2022.
1 June 2022
Quick facts
| Lead sponsor | National Allergy Research Center, Denmark |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | basic science |
| Enrollment | 26 |
| Start date | 1 March 2021 |
| Primary completion | 1 June 2022 |
| Estimated completion | 1 June 2022 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Nickel sulfate hexahydrate
Conditions studied
- Nickel; Eczema — all drugs for Nickel; Eczema →
- Nickel Sensitivity — all drugs for Nickel Sensitivity →
- Allergy — all drugs for Allergy →
- Inflammatory Response — all drugs for Inflammatory Response →
Sponsor
National Allergy Research Center, Denmark
Who can join
Adults 18 to 65, any sex, with Nickel; Eczema or Nickel Sensitivity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A dose-response study on the immune phenotype of allergic nickel dermatitis on a previously exposed skin area.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04438330
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Nickel; Eczema
Currently open trials in the same condition.
- NCT06529913 — Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases · NA · recruiting
Other National Allergy Research Center, Denmark trials
Trials by the same sponsor.
- NCT06042309 — Contact Allergy to Rubber Accelerators - a Clinical Study · NA · completed
- NCT06130462 — Detection of Aluminium-reactive T-lymphocytes in Patients With Vaccination Granulomas · NA · completed
- NCT04921163 — Children With Aluminium Contact Allergy: Oral Exposure Study · NA · completed
- NCT04790799 — Occupational Hand Eczema - Testing of a Prevention-concept · NA · completed
- NCT04438135 — Children With Aluminium Contact Allergy: Cutaneous Exposure Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04438330 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Allergy Research Center, Denmark
- Last refreshed: 4 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04438330.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing